Cerebras Systems Inc. (NASDAQ:CBRS) shares are trading lower Wednesday as a new wave of shares hits the market. There are also reports that OpenAI’s newly unveiled GPT-6.1 Sol Ultrafast is not running[...]
Read moreArticles
Trump Warns Xi Against Helping Iran in War; China Assures U.S. it Will Stop Support
U.S. President Donald Trump pressed Chinese President Xi Jinping during their Washington talks to halt any direct or indirect assistance to Iran, while Tehran said Beijing has assured it that ties wit[...]
Read moreServiceNow, Quanta Services & More on CNBC’s ‘Final Trades’
On CNBC’s “Halftime Report Final Trades,” Joshua Brown, co-founder and CEO of Ritholtz Wealth Management, picked F/M US Treasury 2 Year Note ETF (NASDAQ:UTWO). Malcolm Ethridge, managing partner at Ca[...]
Read moreCracker Barrel Battles Consumer Pressure With $7.99 Breakfast, $8.99 Early Dine Deals
Cracker Barrel Old Country Store Inc. (NASDAQ:CBRL) stock rose Wednesday after the restaurant chain reported better-than-expected fiscal fourth-quarter results, even as it lowered its fiscal 2027 sale[...]
Read moreMeta Stock Is Surging: What’s Happening Today?
Meta Platforms Inc. (NASDAQ:META) shares are popping Monday. Wells Fargo raised its price target on the stock, with additional excitement building around this week’s Meta Connect event. Here’s what yo[...]
Read moreCFTC Expands Regulatory Relief for Crypto Developers
Federal regulators are moving ahead with crypto-friendly measures after the CLARITY Act stalled in the Senate. The CFTC on Thursday expanded regulatory relief for software developers just hours after[...]
Read moreTarget, Truist Financial And More On CNBC’s ‘Final Trades’
On CNBC’s “Halftime Report Final Trades,” Joshua Brown, co-founder and CEO of Ritholtz Wealth Management, picked Target Corporation (NYSE:TGT). According to recent news, Target on Monday reported that[...]
Read moreScholar Rock Marks ‘Defining Moment’ with First Muscle-Targeted Treatment for Spinal Muscular Atrophy
The U.S. Food and Drug Administration on Friday approved ISEMBYLD (apitegromab-mstn) from Scholar Rock (NASDAQ:SRRK) for spinal muscular atrophy (SMA) in adults and pediatric patients aged 2 years and[...]
Read moreAs the Rotation Dies, Wall Street Is Blaming the Wrong Flaw in Small Caps
Critics have long pointed to an equity market breadth issue, with a narrow basket of tech giants driving most index returns. While participation improved through the second quarter, the broadening did[...]
Read moreLutnick Heads to Mexico for Trade Talks, While Trump Escalates Trade War With Canada: Report
Commerce Secretary Howard Lutnick is reportedly set to travel to Mexico to engage in crucial trade talks with top officials, including President Claudia Sheinbaum. Lutnick is expected to discuss U.S. [...]
Read more